Discovery of complex pathways from observational data
- PMID: 20683892
- PMCID: PMC2922970
- DOI: 10.1002/sim.3962
Discovery of complex pathways from observational data
Abstract
Unraveling complex interactions has been a challenge in epidemiologic research. We introduce a pathway modeling framework that discovers plausible pathways from observational data, and allows estimation of both the net effect of the pathway and the types of interactions occurring among genetic or environmental risk factors. Each discovered pathway structure links combinations of observed variables through intermediate latent nodes to a final node, the outcome. Biologic knowledge can be readily applied in this framework as a prior on pathway structure to give preference to more biologically plausible models, thereby providing more precise estimation of Bayes factors for pathways of greatest interest by Markov Chain Monte Carlo (MCMC) methods.Data were simulated for binary inputs of which only a subset was involved in different pathway topologies. Our algorithm was then used to recover the pathway from the simulated data. The posterior distributions of inputs, pairwise and higher-order interactions, and topologies were obtained by MCMC methods. The evidence in favor of a particular pathway or interaction was summarized using Bayes factors. Our method can correctly identify the risk factors and interactions involved in the simulated pathway. We apply our framework to an asthma case-control data set with polymorphisms in 12 genes.
Copyright (c) 2010 John Wiley & Sons, Ltd.
Figures
References
-
- Thomas DC. The Need for a systematic approach to complex pathways in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14(3) - PubMed
-
- Conti DV, et al. Bayesian modeling of complex metabolic pathways. Hum Hered. 2003;56(1–3):83–93. - PubMed
-
- Conti D, et al. Using ontologies in hierarchical modeling of genes and exposures in biological pathways. Phenotypes and Endophenotypes: Foundations for Genetic Studies of Nicotine Use and Dependence. 2009. NCI Tobacco Control Monograph Series. :539–584.
Publication types
MeSH terms
Grants and funding
- R01ES016813/ES/NIEHS NIH HHS/United States
- R01 ES016813/ES/NIEHS NIH HHS/United States
- P01ES011627/ES/NIEHS NIH HHS/United States
- P50 CA084735/CA/NCI NIH HHS/United States
- R01 HL087680/HL/NHLBI NIH HHS/United States
- R01HL061768/HL/NHLBI NIH HHS/United States
- U01ES15090/ES/NIEHS NIH HHS/United States
- P30 ES007048/ES/NIEHS NIH HHS/United States
- U01 ES015090/ES/NIEHS NIH HHS/United States
- R01 DA002277/DA/NIDA NIH HHS/United States
- P30ES07048/ES/NIEHS NIH HHS/United States
- R01 HL061768/HL/NHLBI NIH HHS/United States
- U01DA020830/DA/NIDA NIH HHS/United States
- R01 ES019876/ES/NIEHS NIH HHS/United States
- P01 ES011627/ES/NIEHS NIH HHS/United States
- U01 DA020830/DA/NIDA NIH HHS/United States
- R01HL087680/HL/NHLBI NIH HHS/United States
- P50CA084735/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources